Terran Biosciences is a cutting-edge biotech platform company based in New York, NY, dedicated to developing groundbreaking therapeutics and technologies for patients with neurological and psychiatric diseases. Their innovative portfolio includes late-stage therapies for schizophrenia, selective serotonin 2A receptor antagonists, drug design advancements for psychedelic therapies, and an AI-enabled imaging software platform.
With a team of experienced biopharma industry professionals and successful physician-entrepreneurs, Terran Biosciences is poised to lead the renaissance in neuroscience. Their pipeline features late-stage assets with the potential to revolutionize patient care, including novel treatments for schizophrenia, Alzheimer's disease, and various neuropsychiatric illnesses.
Generated from the website